Log In
Sign Up
Forgotten Password
Upgrade to a paid membership and never see an advert again!
Why do we display adverts? The advertisements supplied by our carefully selected sponsors enable us to host and support the company data we share with our free members.
Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock CLERICAL MEDICAL INVESTMENT FUND MANAGERS LIMITED's Credit Report?
Buy This Report
Upgrade to Lite
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to Lite
Trinity Road,
Halifax,
Calderdale,
HX1 2RG
CLERICAL MEDICAL INVESTMENT FUND MANAGERS LIMITED
Private limited with Share Capital
Company not trading
19 February 1993
74990 Non-trading company - Non-trading company
Available to 03 Jul 2025. Next accounts due by 30 Sep 2026
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Mrs Rachel Anne Messenger | Director | ||
| Mr Jacques Lodewickus Bezuidenhout | Director | ||
| Mrs Karen Joanne McKay | Company Secretary |
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £2,000.00 | £2,000.00 | £2,000.00 | £0.00 | £27,000.00 |
| Net Worth | £4,831,000.00 | £4,831,000.00 | £4,832,000.00 | £4,831,000.00 | £4,832,000.00 |
| Total Current Liabilities | £0.00 | £0.00 | £0.00 | £1,000.00 | £0.00 |
| Total Current Assets | £4,831,000.00 | £4,831,000.00 | £4,832,000.00 | £4,833,000.00 | £27,000.00 |
Detailed answers about CLERICAL MEDICAL INVESTMENT FUND MANAGERS LIMITED, including incorporation, status, business activity, and accounts information.
CLERICAL MEDICAL INVESTMENT FUND MANAGERS LIMITED was officially incorporated on 19 February 1993 and is registered under company number 02792006. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
Private limited with Share Capital. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
CLERICAL MEDICAL INVESTMENT FUND MANAGERS LIMITED's current status is NonActive. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
CLERICAL MEDICAL INVESTMENT FUND MANAGERS LIMITED operates in the following sector: 74990 Non-trading company - Non-trading company . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
The registered office address of CLERICAL MEDICAL INVESTMENT FUND MANAGERS LIMITED is Trinity Road, Halifax, Calderdale, HX1 2RG. This is the official address filed with Companies House for legal and statutory correspondence.
Based on the latest accounts up to 03 Jul 2025, CLERICAL MEDICAL INVESTMENT FUND MANAGERS LIMITED has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 30 Sep 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.